Despite these encouraging observations, the overall anti-tumor immune response elicited by HIFU is still insufficient, presumably because of the immune tolerance developed during tumorigenesis [19], in which signal transducer and activator of transcription 3 (STAT3) has been shown to play a critical role [20]–[22]. The gene discussed is STAT3; the disease is neoplasm.